Blood test guides leukemia treatment duration in new drug combo trial
NCT ID NCT05677919
Summary
This study is testing a two-drug combination (pirtobrutinib and venetoclax) for people with previously untreated chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). The main goal is to see if using a sensitive blood test that detects tiny amounts of leftover cancer cells can help determine how long patients need treatment. Participants will take the drugs for up to 27 cycles (about 2 years) and then be followed to see how well the cancer is controlled and how long the response lasts.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC LYMPHOCYTIC LEUKEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Mayo Clinic in Rochester
Rochester, Minnesota, 55905, United States
Conditions
Explore the condition pages connected to this study.